Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised 10x Genomics, Inc in connection with the acquisition of Spatial Transcriptomics
Mandate

Vinge has advised 10x Genomics, Inc in connection with the acquisition of Spatial Transcriptomics

December 11, 2018 M&A

Spatial Transcriptomics is active within the field of spatial genomics.

 

10x Genomics will continue to operate Spatial Transcriptomics out of their existing offices in Stockholm, with plans to grow their presence in Sweden.

Vinge’s team consisted of, among others, partners Christina Kokko and Kristina Ekberg as well as associates Anna Thoms, Klara Secher, Sophia Holm, Lova Unge, Stina Bengtsson and Frida Ställborn.

Related

Vinge advises HealthCap in conjunction with an investment in Neobiomics

 HealthCap is investing in Neobiomics AB, which develops products in the neonatal field. Neobiomics’ flagship product, Proprems, is a probiotic dietary supplement developed for preterm infants.
May 22, 2026

Vinge advises Sveafastigheter in its merger with KlaraBo

 Vinge advises Sveafastigheter AB (publ) in its merger with KlaraBo Sverige AB.
May 22, 2026

Vinge advises Lagercrantz Group in conjunction with the acquisition of Stalon

 Lagercrantz Group Aktiebolag has acquired 88 per cent of the shares in Stalon AB, a Swedish manufacturer of silencers for hunting firearms. The company is based in Stalon, which is located outside Vilhelmina, where the company conducts development and production in its own facilities.
May 21, 2026